C164H292F2N32O8 — CID 158336054
1-(1,3-benzodioxol-5-ylmethyl)-4-tert-butylpiperazine;1-tert-butyl-4-(2,4-difluorophenyl)piperazine;3-[tert-butyl(methyl)amino]propanenitrile;1-tert-butyl-4-phenylpiperidin-4-ol;2-(4-tert-butylpiperazin-1-yl)ethanol;3-(4-tert-butylpiperazin-1-yl)propanenitrile;2-(4-tert-butylpiperazin-1-yl)pyrazine;2-(4-tert-butylpiperazin-1-yl)pyrimidine;1-tert-butylpiperidine-4-carboxamide;2-(1-tert-butylpiperidin-4-yl)ethanol;1-tert-butyl-4-pyridin-2-ylpiperazine;(1-tert-butylpyrrolidin-2-yl)methanol;N-methyl-N-(pyridin-3-ylmethyl)propan-2-amine;4-[2-(4-propan-2-ylpiperazin-1-yl)ethyl]morpholine (PubChem CID 158336054) has the molecular formula C164H292F2N32O8 and a molecular weight of 2878.35 g/mol. Its IUPAC name is 1-(1,3-benzodioxol-5-ylmethyl)-4-tert-butylpiperazine;1-tert-butyl-4-(2,4-difluorophenyl)piperazine;3-[tert-butyl(methyl)amino]propanenitrile;1-tert-butyl-4-phenylpiperidin-4-ol;2-(4-tert-butylpiperazin-1-yl)ethanol;3-(4-tert-butylpiperazin-1-yl)propanenitrile;2-(4-tert-butylpiperazin-1-yl)pyrazine;2-(4-tert-butylpiperazin-1-yl)pyrimidine;1-tert-butylpiperidine-4-carboxamide;2-(1-tert-butylpiperidin-4-yl)ethanol;1-tert-butyl-4-pyridin-2-ylpiperazine;(1-tert-butylpyrrolidin-2-yl)methanol;N-methyl-N-(pyridin-3-ylmethyl)propan-2-amine;4-[2-(4-propan-2-ylpiperazin-1-yl)ethyl]morpholine.
| Compound Name | 1-(1,3-benzodioxol-5-ylmethyl)-4-tert-butylpiperazine;1-tert-butyl-4-(2,4-difluorophenyl)piperazine;3-[tert-butyl(methyl)amino]propanenitrile;1-tert-butyl-4-phenylpiperidin-4-ol;2-(4-tert-butylpiperazin-1-yl)ethanol;3-(4-tert-butylpiperazin-1-yl)propanenitrile;2-(4-tert-butylpiperazin-1-yl)pyrazine;2-(4-tert-butylpiperazin-1-yl)pyrimidine;1-tert-butylpiperidine-4-carboxamide;2-(1-tert-butylpiperidin-4-yl)ethanol;1-tert-butyl-4-pyridin-2-ylpiperazine;(1-tert-butylpyrrolidin-2-yl)methanol;N-methyl-N-(pyridin-3-ylmethyl)propan-2-amine;4-[2-(4-propan-2-ylpiperazin-1-yl)ethyl]morpholine |
|---|---|
| PubChem CID | 158336054 |
| Molecular Formula | C164H292F2N32O8 |
| Molecular Weight | 2878.35 g/mol |
| Exact Mass | 2876.34 |
| IUPAC Name | 1-(1,3-benzodioxol-5-ylmethyl)-4-tert-butylpiperazine;1-tert-butyl-4-(2,4-difluorophenyl)piperazine;3-[tert-butyl(methyl)amino]propanenitrile;1-tert-butyl-4-phenylpiperidin-4-ol;2-(4-tert-butylpiperazin-1-yl)ethanol;3-(4-tert-butylpiperazin-1-yl)propanenitrile;2-(4-tert-butylpiperazin-1-yl)pyrazine;2-(4-tert-butylpiperazin-1-yl)pyrimidine;1-tert-butylpiperidine-4-carboxamide;2-(1-tert-butylpiperidin-4-yl)ethanol;1-tert-butyl-4-pyridin-2-ylpiperazine;(1-tert-butylpyrrolidin-2-yl)methanol;N-methyl-N-(pyridin-3-ylmethyl)propan-2-amine;4-[2-(4-propan-2-ylpiperazin-1-yl)ethyl]morpholine |
| SMILES | CC(C)(C)N1CCC(C(N)=O)CC1.CC(C)(C)N1CCC(CCO)CC1.CC(C)(C)N1CCC(O)(c2ccccc2)CC1.CC(C)(C)N1CCCC1CO.CC(C)(C)N1CCN(CCC#N)CC1.CC(C)(C)N1CCN(CCO)CC1.CC(C)(C)N1CCN(Cc2ccc3c(c2)OCO3)CC1.CC(C)(C)N1CCN(c2ccc(F)cc2F)CC1.CC(C)(C)N1CCN(c2ccccn2)CC1.CC(C)(C)N1CCN(c2cnccn2)CC1.CC(C)(C)N1CCN(c2ncccn2)CC1.CC(C)N(C)Cc1cccnc1.CC(C)N1CCN(CCN2CCOCC2)CC1.CN(CCC#N)C(C)(C)C |
| InChI | InChI=1S/C16H24N2O2.C15H23NO.C14H20F2N2.C13H27N3O.C13H21N3.2C12H20N4.C11H21N3.C11H23NO.C10H22N2O.C10H20N2O.C10H16N2.C9H19NO.C8H16N2/c1-16(2,3)18-8-6-17(7-9-18)11-13-4-5-14-15(10-13)20-12-19-14;1-14(2,3)16-11-9-15(17,10-12-16)13-7-5-4-6-8-13;1-14(2,3)18-8-6-17(7-9-18)13-5-4-11(15)10-12(13)16;1-13(2)16-7-5-14(6-8-16)3-4-15-9-11-17-12-10-15;1-13(2,3)16-10-8-15(9-11-16)12-6-4-5-7-14-12;1-12(2,3)16-8-6-15(7-9-16)11-10-13-4-5-14-11;1-12(2,3)16-9-7-15(8-10-16)11-13-5-4-6-14-11;1-11(2,3)14-9-7-13(8-10-14)6-4-5-12;1-11(2,3)12-7-4-10(5-8-12)6-9-13;1-10(2,3)12-6-4-11(5-7-12)8-9-13;1-10(2,3)12-6-4-8(5-7-12)9(11)13;1-9(2)12(3)8-10-5-4-6-11-7-10;1-9(2,3)10-6-4-5-8(10)7-11;1-8(2,3)10(4)7-5-6-9/h4-5,10H,6-9,11-12H2,1-3H3;4-8,17H,9-12H2,1-3H3;4-5,10H,6-9H2,1-3H3;13H,3-12H2,1-2H3;4-7H,8-11H2,1-3H3;4-5,10H,6-9H2,1-3H3;4-6H,7-10H2,1-3H3;4,6-10H2,1-3H3;10,13H,4-9H2,1-3H3;13H,4-9H2,1-3H3;8H,4-7H2,1-3H3,(H2,11,13);4-7,9H,8H2,1-3H3;8,11H,4-7H2,1-3H3;5,7H2,1-4H3 |
| InChIKey | GQPBDAOUWWXVHL-UHFFFAOYSA-N |
| XLogP | 22.49 |
| TPSA | 351.14 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 39 |
| Rotatable Bonds | 24 |
| Heavy Atoms | 206 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2878.35 |
| LogP ≤ 5 | 22.49 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 39 |